229 related articles for article (PubMed ID: 18953369)
1. [Rare diseases. Concept, epidemiology and state of the question in Spain].
Posada De la Paz M; Martín-Arribas C; Ramírez A; Villaverde A; Abitua I
An Sist Sanit Navar; 2008; 31 Suppl 2():9-20. PubMed ID: 18953369
[TBL] [Abstract][Full Text] [Related]
2. Drugs for rare diseases: mixed assessment in Europe.
Prescrire Int; 2007 Feb; 16(87):36-42. PubMed ID: 17323539
[TBL] [Abstract][Full Text] [Related]
3. [Hope for patients with rare diseases--"orphan" drugs].
Kuzelová M; Kubácková K; Palágyi M; Smíd M
Cas Lek Cesk; 2006; 145(4):296-300. PubMed ID: 16639930
[TBL] [Abstract][Full Text] [Related]
4. Translation of rare disease research into orphan drug development: disease matters.
Heemstra HE; van Weely S; Büller HA; Leufkens HG; de Vrueh RL
Drug Discov Today; 2009 Dec; 14(23-24):1166-73. PubMed ID: 19818412
[TBL] [Abstract][Full Text] [Related]
5. Issues surrounding orphan disease and orphan drug policies in Europe.
Denis A; Mergaert L; Fostier C; Cleemput I; Simoens S
Appl Health Econ Health Policy; 2010; 8(5):343-50. PubMed ID: 20804226
[TBL] [Abstract][Full Text] [Related]
6. [Surveillance of rare diseases in Spain: Spanish Registry of Rare Diseases (ReeR).].
Vicente E; Ardanaz E; Ramalle-Gómara E; Echevarría LJ; Mira MP; Chalco-Orrego JP; Benito C; Guardiola-Vilarroig S; Mallol C; Guinaldo JM; Carrillo P; Cáffaro M; Compés ML; Caro MN; Alonso V; Soler P
Rev Esp Salud Publica; 2021 Nov; 95():. PubMed ID: 34725319
[TBL] [Abstract][Full Text] [Related]
7. [Orphan drugs. Drugs for treatment of rare diseases].
Hennemann A
Med Monatsschr Pharm; 2004 Aug; 27(8):256-9. PubMed ID: 15382448
[No Abstract] [Full Text] [Related]
8. [Orphan diseases, rare diseases, time to get mobilised].
Cordier JF
Rev Prat; 2006 Jan; 56(2):123-4. PubMed ID: 16584035
[No Abstract] [Full Text] [Related]
9. Rare diseases: the bane of modern society and the quest for cures.
Azie N; Vincent J
Clin Pharmacol Ther; 2012 Aug; 92(2):135-9. PubMed ID: 22814654
[TBL] [Abstract][Full Text] [Related]
10. Rare diseases in disabled children: an epidemiological survey.
Guillem P; Cans C; Robert-Gnansia E; Aymé S; Jouk PS
Arch Dis Child; 2008 Feb; 93(2):115-8. PubMed ID: 17942587
[TBL] [Abstract][Full Text] [Related]
11. [Orphanet and the Dutch Steering Committee Orphan Drugs. A European and Dutch databank of information on rare diseases].
Liem SL
Ned Tijdschr Tandheelkd; 2008 Nov; 115(11):621-3. PubMed ID: 19058507
[TBL] [Abstract][Full Text] [Related]
12. [Orphanet: a European database for rare diseases].
Weinreich SS; Mangon R; Sikkens JJ; Teeuw ME; Cornel MC
Ned Tijdschr Geneeskd; 2008 Mar; 152(9):518-9. PubMed ID: 18389888
[TBL] [Abstract][Full Text] [Related]
13. [Orphan drugs and orphan diseases].
Campos-Castelló J
Rev Neurol; 2001 Aug 1-15; 33(3):216-20. PubMed ID: 11588712
[TBL] [Abstract][Full Text] [Related]
14. [Orphan drugs--medications for patients with rare diseases].
Thielke D; Thyssen JP; Hansen BJ
Ugeskr Laeger; 2006 Jun; 168(23):2236-8. PubMed ID: 16768975
[TBL] [Abstract][Full Text] [Related]
15. Call for a national plan for rare diseases.
Jaffe A; Zurynski Y; Beville L; Elliott E
J Paediatr Child Health; 2010 Jan; 46(1-2):2-4. PubMed ID: 19943870
[TBL] [Abstract][Full Text] [Related]
16. Perspectives for improving the evaluation and access of therapies for rare lung diseases in Europe.
Luisetti M; Balfour-Lynn IM; Johnson SR; Miravitlles M; Strange C; Trapnell BC; van Bronswijk H; Vogelmeier C
Respir Med; 2012 Jun; 106(6):759-68. PubMed ID: 22414566
[TBL] [Abstract][Full Text] [Related]
17. Optimal therapy for rare disorders and genetic diseases: ethical and political challenges.
MacLeod S
Proc West Pharmacol Soc; 2007; 50():21-3. PubMed ID: 18605224
[TBL] [Abstract][Full Text] [Related]
18. Stroke in Spain: epidemiologic incidence and patterns; a health sentinel network study.
Vega T; Zurriaga O; Ramos JM; Gil M; Alamo R; Lozano JE; López A; Miralles MT; Vaca P; Alvarez Mdel M;
J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):11-6. PubMed ID: 19110138
[TBL] [Abstract][Full Text] [Related]
19. [Orphan diseases].
Loizzo A; Tebano MT
Recenti Prog Med; 1993 Nov; 84(11):786-93. PubMed ID: 8290793
[TBL] [Abstract][Full Text] [Related]
20. Creating a European Union framework for actions in the field of rare diseases.
Moliner AM
Adv Exp Med Biol; 2010; 686():457-73. PubMed ID: 20824460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
